Floatz logo

ROPIVACAINE

Cerebral Palsy

University of California, Los AngelesSmall moleculePhase 4 / ApprovedActive
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Cerebral Palsy cohort.

Asset / SponsorPhaseRating
TRIHEXYPHENIDYL
Sathbhavana Brain Clinic
Phase 4BB
Bxcl501
Joseph Cravero
Phase 4BB
LAMOTRIGINE
Sathbhavana Brain Clinic
Phase 4BB
Tetrabenazine
Sathbhavana Brain Clinic
Phase 4BB
Amitriptyline
Sathbhavana Brain Clinic
Phase 4BB

View all 23 →

Same molecule, other indications

ROPIVACAINE is also rated in:

post-operative pain, non-human animalDormant
BBB
Indicative ·
76 / 100
View asset →
Knee Pain ChronicDormant
BBB
Indicative ·
76 / 100
View asset →
osteoarthritis, hipDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →